Neumedicines Inc. is an emerging therapeutic biotechnology company focused on developing and commercializing innovative and proprietary products and approaches that address unmet clinical and societal needs in the areas of oncology, hematology, and immunology. The company operates from its headquarters in Pasadena, California.
Neumedicines' lead product candidate is recombinant human interleukin-12 (rHuIL-12), a heterodimeric glycoprotein and cytokine. rHuIL-12 is being developed under the trade name HemaMax™ for various clinical indications, including hematopoietic syndrome of acute radiation syndrome (HSARS), skin cancers and other solid tumors, and blood disorders and malignancies.
Company Details
- Employees
- 10
- Founded
- 2003
- Address
- 133 North Altadena Drive, Pasadena,california 91107,united States
- Phone
- 6268443810
- in****@****nes.com
- Industry
- Biotechnology
- Website
- neumedicines.com
- HQ
- Pasadena, California
Neumedicines Inc. Questions
Neumedicines Inc.'s helpline number is 6268443810
Neumedicines Inc.'s website is neumedicines.com
Neumedicines Inc.'s LinkedIn profile is https://www.linkedin.com/company/neumedicines
Neumedicines Inc. has
10 employees.
View email and phone details for 10
employees at Neumedicines Inc..
Neumedicines Inc.'s industry is
Biotechnology
Neumedicines Inc.'s top competitors are
Ichor Medical Systems,
Pacific Neuroscience Medical Group,
Alsp, Inc.,
Theragent Inc,
Sbh Sciences,
Abiocode,
Cdr3 Therapeutics,
Rmc Pharmaceutical Solutions,
Ladrx Corporation,
Frontera Technology Ventures, Inc..
Neumedicines Inc.'s support email address is info@neumedicines.com
Neumedicines Inc.'s categories are Biotechnology
Neumedicines Inc.'s founding year is 2003
